跳至主要内容
临床试验/NCT04461912
NCT04461912Unknown不适用

Development of a Medical Device Based on Ultrasounds for Objective Cataract Characterization and Optimal Phacoemulsification Energy Evaluation

University of Coimbra1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2021年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Presence of Cataract

研究概览

简要总结

This study aims to assess the performance of an ultrasonic system for automatic classification of cataract type and severity, as well as the estimation of the optimal phacoemulsification energy. Ultrasonic signals from the lens will be acquired with the Experimental Medical Device (ESUS) in participants with cataract, and in healthy subjects (control).

The proposed technique may represent an important advance in cataract treatment. The quantitative and automatic classification of cataract type and severity, and the estimation of the optimal phacoemulsification energy is may represent a valuable tool for surgical planning, reducing complications associated to excessive levels of phacoemulsification energy, as well as the times spent on surgeries. This device may be relevant not only for patients, but also for public health systems, reducing waiting lists and associated costs.

详细描述

This is a prospective, pivotal, non-blinded study. Fifty (50) participants will be recruited at the Coimbra Surgical Center of Portugal. The study will be conducted on subjects with age-related cataract, and on healthy subjects as control group. Since this is a pilot study, no sample size estimation has been implemented. The statistical power will be determined at the end of the study. Only per-protocol participants will be considered on statistical analysis.

Procedures involved. The ultrasonic system (Experimental Medical Device - ESUS) works in A-scan mode, with an acoustic working frequency of 20 MHz. From the ultrasonic signals backscattered from the lenses, acoustic parameters will be extracted, and used for automatic algorithms implementation. This study will be implemented once.

Slit lamp with LOCS III classification will be used as comparator. Contrast sensitivity test results will be used for incipient cataract detection, where slit lamp may present some limitations. Optical coherence tomography and specular microscopy will help on detecting postoperative complications; other complications identified by the physician will be also considered. Surgical parameters as phacoemulsification energy and surgical time will help on phacoemulsification energy evaluation.

Safety assessment. The system uses an ophthalmic probe. There are not anticipated adverse events related to the procedures involved in the use of the ultrasonic system, or any other procedure in the protocol. The safety conditions will be monitored through the occurrence of unanticipated adverse events or serious adverse events. If these situations occur, the event will be reported to the competent authorities (in agreement with the current regulation) and the corrective actions will be implemented.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
50 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Cataract group:
  • •Patients with age-related cataract;
  • •Indication of phacoemulsification surgery
  • •Control group:
  • •Patients without cataract

排除标准

  • •Presence of any other ophthalmological condition or systemic disease that could affect the results

研究组 & 干预措施

Cataract

Experimental

Participants with diverse types and severities of cataract, that should realize phacoemulsification surgery

干预措施: Eye Scan Ultrasound System (ESUS) (Device)

Control

Placebo Comparator

Participants on which the presence of cataract have been excluded

干预措施: Eye Scan Ultrasound System (ESUS) (Device)

结局指标

主要结局

Presence of Cataract

时间窗: baseline

Presence of cataract obtained with the Experimental Medical Device (ESUS)

次要结局

  • Cataract classification(baseline)
  • Cataract hardness(before the intervention/procedure/surgery)
  • Phacoemulsification energy(immediately after the intervention/procedure/surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jaime Batista Santos

Investigator Responsible

University of Coimbra

研究点 (1)

Loading locations...

相似试验